You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
翰森制药(03692.HK)上限定价每股14.26港元国际发售获大幅超购
格隆汇 06-13 14:30

格隆汇6月13日丨翰森制药(03692.HK)公布,全球发售551,280,000股,其中香港发售38,590,000股,国际发售512,690,000股;发售价每股14.26港元,上限定价;每手2,000股;预期2019年6月14日上市。

公告显示,香港公开发售获适度超额认购,相当于香港公开发售初步可供认购总数的约11.77倍。公开发售的申请人将获配发及发行3859万股发售股份,占全球发售初步可供认购的发售股份总数约7%(假设并无行使超额配股权)。

国际发售获大幅超额认购,分配给国际发售承配人的发售股份最终数目约为5.13亿股发售股份,相当于全球发售初步可供认购发售股份总数约93%(假设并无行使超额配股权)。

基石投资者方面,认购总数约为1.89亿股股份,合共相当于(i)全球发售后的公司已发行股本总数约3.32%;及(ii)全球发售的发售股份数目约34.36%(假设并无行使超额配股权)。

其中,GIC Private Limited已认购3853.2万股股份,Boyu Capital Opportunities Master Fund已认购3302.6万股股份。

公告称,所得款项净额约为76.4亿港元。其中,约45%用于研发项目;约25%用于公司的生产体系,建设新生产线,升级现有生产设施并提高其自动化水平;约20%用于加强销售及学术推广;约10%用于营运资金及其他一般企业用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account